VF
VKTXW

Virtu Financial’s Viking Therapeutics, Inc. VKTXW Stock Holding History

Virtu Financial’s Portfolio VKTXW Stock Details VKTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-43,100
Closed -$109K – 2880
2017
Q4 		$109K Buy
+43,100
New +$75.2K 0.01% 1891

Other funds holding VKTXW

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's VKTXW Position: Q1 2018 in Review

Virtu Financial sold out of Viking Therapeutics, Inc. (VKTXW) in Q1 2018, closing a stake of 43,100 shares — an estimated $109K sold.

Virtu Financial first reported a position in VKTXW in Q4 2017 and held it in 1 quarter. The position peaked at $109K in Q4 2017. 6 funds tracked by Wall St. Rank hold VKTXW as of Q1 2018.

  • Virtu Financial reported no remaining Viking Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Virtu Financial sold 43,100 Viking Therapeutics, Inc. shares in Q1 2018, an estimated $109K.
  • Virtu Financial first reported a position in Viking Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • Virtu Financial's Viking Therapeutics, Inc. position peaked at $109K in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.